Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Genmab A (GMAB) Common Equity: 2018-2020

Historic Common Equity for Genmab A (GMAB) over the last 3 years, with Dec 2020 value amounting to $2.2 billion.

  • Genmab A's Common Equity rose 30.33% to $2,405 in Q2 2021 from the same period last year, while for Jun 2021 it was $2,405, marking a year-over-year increase of 30.33%. This contributed to the annual value of $2.2 billion for FY2020, which is 52.05% up from last year.
  • Latest data reveals that Genmab A reported Common Equity of $2.2 billion as of FY2020, which was up 52.05% from $1.5 billion recorded in FY2019.
  • Over the past 5 years, Genmab A's Common Equity peaked at $2.2 billion during FY2020, and registered a low of $886.1 million during FY2018.
  • Its 3-year average for Common Equity is $1.5 billion, with a median of $1.5 billion in 2019.
  • Data for Genmab A's Common Equity shows a peak YoY spiked of 64.87% (in 2019) over the last 5 years.
  • Yearly analysis of 3 years shows Genmab A's Common Equity stood at $886.1 million in 2018, then soared by 64.87% to $1.5 billion in 2019, then skyrocketed by 52.05% to $2.2 billion in 2020.